Proscia

Proscia is a leading medical technology company and the creator of Concentriq, a global Best in KLAS award-winning enterprise digital pathology software platform built to modernize clinical diagnostics and life sciences research. The software transforms traditional, glass-slide-based pathology by converting tissue samples into high-resolution whole slide images (WSIs). Acting as a central system of action, Concentriq unifies multi-site teams, clinical metadata, and advanced AI applications into a single, secure cloud or on-premise ecosystem. By bridging the gap between physical tissue morphology and digital data science, Proscia helps laboratories eliminate manual silos, optimize data management, and accelerate high-precision medicine workloads.

Concentriq features a deeply integrated, multi-modal AI layer built explicitly to handle high-judgment clinical and operational tasks without disrupting a pathologist's natural flow state. The platform’s advanced vision and language models eliminate the invisible, repetitive labor surrounding case review by providing intelligent slide navigation, automated tissue orientation, and real-time region-of-interest analysis. For laboratory managers, embedded AI helps balance multi-site workflows, recommend specialized stain panels, and optimize resources. Furthermore, the platform includes automated storage tiering, which dynamically matches data placement to an institution's historical usage patterns, cutting long-term cloud storage costs by more than half while maintaining strict, governed access.

For biopharmaceutical companies and contract research organizations (CROs), Proscia provides a scalable digital backbone designed to streamline the entire drug development pipeline, from early-stage discovery to late-stage clinical trials. Scientists can utilize plain-language search tools to instantly scan across vast repositories of tissue data, clinical histories, and translational findings to identify promising biomarker candidates. During clinical development, Concentriq helps research teams predict biomarker expression profiles during the pre-screening phase, ensuring sponsors can rapidly identify eligible cohorts and hit enrollment deadlines. This automated standardization ensures that diverse, global multi-site trials evaluate patient tissue against identical criteria to generate highly reproducible results.

Yes, Proscia operates on a completely open, vendor-agnostic architecture engineered to prevent restrictive software lock-in and support the evolving technological needs of modern labs. Concentriq is compatible with over 45 scanner models and handles all major proprietary image formats alongside standard DICOM and TIFF files, allowing labs to change their hardware infrastructure smoothly. It features robust, bi-directional REST APIs that connect natively with existing Laboratory Information Systems (LIS) and Laboratory Information Management Systems (LIMS). To ensure absolute quality and compliance in highly regulated environments, the platform is GxP-ready for life sciences research, fully HIPAA-compliant, and carries FDA 510(k) clearance and CE-IVDR marks for primary clinical diagnosis.